UFP Technologies, Inc. Proceeds from Long-Term Debt Issued
UFP Technologies, Inc. (UFPT) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-02-27
- UFP Technologies, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $0.00.
- UFP Technologies, Inc. proceeds from issuance of long-term debt for the quarter ending 2024-12-31 was $0.00.
- UFP Technologies, Inc. proceeds from issuance of long-term debt for the quarter ending 2023-12-31 was $0.00.
- UFP Technologies, Inc. proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $0.00.
- UFP Technologies, Inc. proceeds from issuance of long-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- UFP Technologies, Inc. proceeds from issuance of long-term debt for fiscal 2024 was $125.00M.
- UFP Technologies, Inc. proceeds from issuance of long-term debt for fiscal 2023 was $0.00.
- UFP Technologies, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 3 month as first filed | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 6 month as first filed | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 9 month as first filed | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | ||||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $125.00M 10-K · filed 2026-02-27 | ||||||
| 2024-09-30 | $125.00M 10-Q · filed 2025-11-07 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | ||||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | |||||||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 | |||||||
| 2021-12-31 | $40.00M 10-K · filed 2024-02-29 | |||||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-16 | |||||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-14 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $20.00M 10-K · filed 2021-03-12 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $20.00M 10-Q · filed 2019-11-08 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $20.00M 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $20.00M 10-Q · filed 2019-05-10 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-11 | $580.00K 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $580.00K 10-Q · filed 2014-11-07 | $579.65K 10-Q · filed 2013-11-07 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $580.00K 10-Q · filed 2014-08-08 | $579.65K 10-Q · filed 2013-08-08 | |||||
| 2013-03-31 | $580.00K 10-Q · filed 2014-05-12 | $579.65K 10-Q · filed 2013-05-10 | ||||||
| 2012-12-31 | $4.38M 10-K · filed 2015-03-13 | $4.38M 10-K · filed 2013-03-15 | ||||||
| 2009-12-31 | $4.00M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |